Clinical Trial Update: A Study to Assess the Efficacy of Inhaled Corticosteroid (ICS) Therapy in Moderate-Severe Bronchial Asthma [Phase 1, Phase 2]

View source ↗

Summary

Novartis completed a Phase 1/2 clinical trial evaluating inhaled corticosteroid therapy in moderate-to-severe asthma. The study's status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Snippet

Sponsor: Novartis | Conditions: Bronchial Asthma | Phase 1, Phase 2 | Status: COMPLETED